R
Residual Dynamics builds fit-for-purpose, semi-mechanistic dynamic models specializing in quantitative systems pharmacology (QSP) and model-informed drug discovery and development (MID3). These models deliver quantitative insight across the drug development pipeline, addressing specific scientific questions. The resulting analysis supports optimized drug properties, preclinical experimental design, and clinical dose regimen selection.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Residual Dynamics builds fit-for-purpose, semi-mechanistic dynamic models specializing in quantitative systems pharmacology (QSP) for drug discovery and development. These models provide quantitative insight to address specific questions across the entire pharmaceutical pipeline. The service supports optimized drug properties, preclinical experimental design, and clinical dose regimen optimization.